Baxter International Inc. Revenue 2007–2025
Baxter International Inc. annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Baxter International Inc. revenue for the quarter ending March 31, 2026 was 2.7 B, a 2.90% increase year-over-year.
- Baxter International Inc. revenue for the twelve months ending March 31, 2026 was 11.0 B, a 4.67% increase year-over-year.
- Baxter International Inc. annual revenue for 2025 was 11.2 B, a 5.72% increase from 2024.
- Baxter International Inc. annual revenue for 2024 was 10.6 B, a 2.66% increase from 2023.
- Baxter International Inc. annual revenue for 2023 was 10.4 B, a 3.01% increase from 2022.
- Baxter International Inc. annual revenue for 2022 was 10.1 B.
Baxter International Inc. (BAX) — Frequently Asked Questions
Baxter International Inc. (BAX) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $10.42B. In fiscal 2025 it reported revenue of $11.24B and net income of -$957M. Explore BAX's stock price, financial statements, earnings history, margins and key ratios below.
What is Baxter International Inc.'s market cap?
Baxter International Inc. (BAX) has a market capitalization of $10.42B.
What is the BAX stock price?
BAX trades at $20.31 (+1.40% on the day).
How much revenue does Baxter International Inc. make?
Baxter International Inc. reported revenue of $11.24B in fiscal 2025.
Is BAX profitable?
In fiscal 2025, Baxter International Inc. reported net income of -$957M.